Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2022-05-18 2022-04-01
Drug Identification Number 02369567 02369567
Brand name DIPHENHYDRAMINE HYDROCHLORIDE INJECTION DIPHENHYDRAMINE HYDROCHLORIDE INJECTION
Common or Proper name DiphenhydrAMINE Hydrochloride Injection DiphenhydrAMINE Hydrochloride Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1mL 1mL
ATC code R06AA R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-03-29 2022-03-29
Estimated end date 2022-05-20 2022-05-02
Actual end date 2022-05-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Due to unforeseen circumstances, we have encountered a supply interruption. Due to unforeseen circumstances, we have encountered a supply interruption.
Health Canada comments